At least 15 babies have been sickened during a recent outbreak of infant botulism.
Nine of the cases have been confirmed as infant botulism type A, with results for the other cases pending, Dr. Erica Pan, health officer for the California Department of Public Health, said on Nov. 10.
Federal and state officials are investigating the botulism outbreak, which has been tied to formula made by the company ByHeart.
Illnesses Start
The cases of botulism started in August, authorities said.Infant botulism occurs when babies eat food or beverages that have spores from a bacterium called Clostridium botulinum.
Formula Recalled
ByHeart, which makes organic formula and is based in New York, on Nov. 8 said it was voluntarily recalling two lots of formula “out of an abundance of caution” and “to remove any potential risk from the market and ensure that the safety and well-being of every baby who uses ByHeart—including our own—will always come first.”- Batch Code: 251261P2, use by: 01 Dec 2026
- Batch Code: 251131P2, use by: 01 Dec 2026
Test Detects Bacteria
Testing conducted by the California Department of Public Health detected bacteria that produce botulinum toxin, the agency said the same day as the recall was announced.The sample was taken from an open can of ByHeart formula that was fed to an infant who fell ill. Officials injected mice with the cultured bacterium and then waited up to four days to see if they got sick.
“These mice got sick really quickly,” Pan said.
Potential Impact on Formula Stock
There is little danger of infant formula shortages because of this outbreak. ByHeart, which was founded in 2016, accounts for an estimated 1 percent of national formula sales, according to the CDC.A baby formula shortage developed in 2021 after four infants were sickened after consuming formula made by Abbott Nutrition.
Two of the babies died. No direct link was found between the Abbott products and the infections caused by Cronobacter sakazakii, but federal officials closed the company’s Michigan plant after contamination and other problems were detected.
Abbott made about half of the formula in the United States at the time.







